SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-021995
Filing Date
2018-12-14
Accepted
2018-12-14 08:32:40
Documents
3
Period of Report
2018-12-13
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20181214_8k.htm 8-K 20604
2 EXHIBIT 3.1 ex_131648.htm EX-3.1 8646
3 ex_131648img001.jpg GRAPHIC 2871
  Complete submission text file 0001437749-18-021995.txt   34875
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 181234624
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1